التفاصيل البيبلوغرافية
| العنوان: |
Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. |
| المؤلفون: |
Bauer, Philip M., Bauer, Eileen M., Rogers, Natasha M., Yao, Mingyi, Feijoo-Cuaresma, Monica, Pilewski, Joseph M., Champion, Hunter C., Zuckerbraun, Brian S., Calzada, Maria J., Isenberg, Jeffrey S. |
| المصدر: |
Cardiovascular Research; Mar2012, Vol. 93 Issue 4, p682-693, 12p |
| مصطلحات موضوعية: |
PULMONARY hypertension, PROMOTERS (Genetics), CAVEOLINS, PROTEINS, VASOCONSTRICTION, VASCULAR resistance, HEART failure, NITRIC-oxide synthases |
| مستخلص: |
Aims Pulmonary arterial hypertension (PAH) is a progressive lung disease characterized by pulmonary vasoconstriction and vascular remodelling, leading to increased pulmonary vascular resistance and right heart failure. Loss of nitric oxide (NO) signalling and increased endothelial nitric oxide synthase (eNOS)-derived oxidative stress are central to the pathogenesis of PAH, yet the mechanisms involved remain incompletely determined. In this study, we investigated the role activated CD47 plays in promoting PAH. Methods and results We report high-level expression of thrombospondin-1 (TSP1) and CD47 in the lungs of human subjects with PAH and increased expression of TSP1 and activated CD47 in experimental models of PAH, a finding matched in hypoxic human and murine pulmonary endothelial cells. In pulmonary endothelial cells CD47 constitutively associates with caveolin-1 (Cav-1). Conversely, in hypoxic animals and cell cultures activation of CD47 by TSP1 disrupts this constitutive interaction, promoting eNOS-dependent superoxide production, oxidative stress, and PAH. Hypoxic TSP1 null mice developed less right ventricular pressure and hypertrophy and markedly less arteriole muscularization compared with wild-type animals. Further, therapeutic blockade of CD47 activation in hypoxic pulmonary artery endothelial cells upregulated Cav-1, increased Cav-1CD47 co-association, decreased eNOS-derived superoxide, and protected animals from developing PAH. Conclusion Activated CD47 is upregulated in experimental and human PAH and promotes disease by limiting Cav-1 inhibition of dysregulated eNOS. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cardiovascular Research is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder